MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST002473/mwtabprimaryOK200Mass SpectrometryESIUlcerative Colitishttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST002473Strain:xdhA | Drug:AzathioprineStrain:WT | Drug:6-mercaptopurineStrain:WT | Drug:AzathioprineStrain:pucD | Drug:AzathioprineStrain:xdhA | Drug:NoneStrain:None | Drug:NoneStrain:None | Drug:6-mercaptopurineStrain:xdhA | Drug:6-mercaptopurineStrain:pucD | Drug:NoneStrain:pucD | Drug:6-mercaptopurineStrain:None | Drug:AzathioprineStrain:WT | Drug:NoneCulture MediaHILIC POSITIVE ION MODE. HILIC NEGATIVE ION MODE.MetabolomicsWorkbenchMetabolomicsVeillonella ParvulaBroad Institute of MIT and HarvardnorepinephrineCDPserotoninthymine-d4thymidine2-hydroxyglutarate5-methoxytryptopholoxalateglutamateranitidineorotate2-deoxyadenosinecytidineglucuronateN6-methyllysineazathioprineGMPmethionine sulfoxideL-alpha-glutamyl-L-lysineadenosinecreatine3-methyladipate/pimelate1H-indole-3cetamidekynurenic aciddTMPhistamineasparaginecAMPN2,N2-dimethylguanosinedimethylglycineornithinecreatininecytosinequinolinatealanineallopurinolmethylthioadenosineN1-acetylsperminepro-glyindolelactatedCMPS-methyl-L-cysteine-S-oxideurate6-mercaptopurineguanosinexanthine3-phosphoglyceratexanthosinelactateN-acetylalanineerythronate/threonateN6,N6,N6-trimethyllysineinosine-15N4alpha-keto-beta-methylvalerate/alpha-ketoisocaproateADP1-methylguanosineN-alpha-acetylarginineadonitol/arabitolhomocitrullinefructose/glucose/galactose_aargininefructose/glucose/galactose_bcystathioninethiamineleucine4-hydroxybenzaldehydesucrose/lactose/trehaloseadipate/methylglutarateisovalerate/valerate/methylbutyrateagmatineguanidinoacetic acidalpha-hydroxybutyrate/beta-hydroxybutyrate/hydroxyisobutyrate3-methylhistidinelysine3-methylglutaconatehexose monophosphatemethionineN-acetylmethionineGABAgentisateUMPalpha-glycerophosphocholinetyrosine2-aminobutyrate2-deoxycytidinenicotinuric acid4-guanidinobutanoic acidproline-betainebutyrateN-carbamoyl-beta-alaninetetrahydro-1-methyl-beta-carboline-3-carboxylateacetyl-galactosaminesuccinateN-acetyltryptophansuberatecadaverineN6-acetyllysinephenylalanineADMAquinateN-acetylleucinenicotinatehomovanillatepyroglutamic aciduracilcarnitinePEPacetylcholinebetainethymineinosineleu-glycyclohexylamineisoleucinemethylguanidineGDPhippurateN-acetylaspartic acidhypoxanthineC3 carnitineglycinephenylacetylglutamine1-methylhistidinebutyrobetaine4-acetamidobutanoateglycocholatepterincitrate/isocitrateCMPniacinamideN-acetylserinetyramineanhydroDglucose/3-hydroxymethylglutarate4-pyridoxate5-methylcytidineaconitateN-acetylglutamatehomoarginineC2 carnitine5-methylcytosineglycocholate-d4O-succinyl homoserine5-hydroxytryptophanhydroxyprolinephosphocholineN6,N6-dimethyllysineS-adenosylhomocysteineglutaminemalonatecholinepyridoxinepantothenatesebacatetryptophanN1-methyl-2-pyridone-5-carboxamidealpha-glycerophosphatemyristoleatesalicylurateitaconateglyceratelinoleoyl ethanolamidehistidine2-aminoheptanoateserineN-acetylglutamineN-acetylputrescineSDMAsuccinyladenosine2-aminoadipateMDA5-hydroxytryptopholpentose monophosphateN1-acetylspermidineN-acetylcarnosine3-methoxyanthranilateN-acetylornithine3-methoxytyramineaspartateputrescinespermidineUDPAMPvaline-d8pipecolic acidtaurineN-acetylphenylalanineurocanic aciderythrose-4-phosphateprolinemalateguaninethreitolNMMA2-hydroxy-3-methylbutyratecitrullinehistidinolprogesteronesorbitolmethylmalonateuridinefumarate/maleateanthranilic acidatenololtrigonellinemesaconatepropionatephenylalanine-d8pseudouridineglutathione oxidizedtryptamineN-acetylhistidine7-methylguanineallopurinol riboside2-hydroxy-3-methylpentanoate/hydroxyisocaproate2-methylguanosinedethiobiotinthreonineadeninevalineectoineimidazoleacetic acidProducts, other disease, host organism, Inflammatory Response, Microbial Competitive Behavior, Inflammations, Bowel Diseases, Product, drug, disorders, secondary metabolites, medical condition, Microbial, Behavior, Competitive Behaviors, Microbial Competitive Behaviors, primary metabolites, Interaction, diseases, inflammatory bowel disease, Pharmaceutical Product, Diseases, disease or disorder, condition, Competitive Behavior, diseases and disorders, Pharmaceutic, metabolites., Microbial Interaction, Microbial Cooperative Behaviors, Drugs, human disease, inflammatory response, Cooperative Behaviors, IBD, Pharmaceutic Preparations, Micrococcus lactilyticus, Microbial Cooperative Behavior, metabolite, inflammation, INFLAMM BOWEL DIS, Micrococcus gazogenes alcalescens anaerobius, non-neoplastic, Drug, disease, Veillonella gazogenes, Preparations, Inflammatory Bowel Diseases, drugs, Cooperative Behavior, Innate Inflammatory Response, medicine, Staphylococcus parvulus, Pharmaceutical, Innate Inflammatory Responses, Veillonella alcalescens, metabolites, Microbial Cooperative, Micrococcus gazogenes, psychogenic IBS, disorder, Homo sapiens disease, autoimmune bowel disorder, Preparation, associated, Behaviors, Inflammatory, Pharmaceutical Products, Innate, Microbial Competitive, Interactions, Pharmaceutical Preparation, Pharmaceuticalsiones., Ionen, ion, Ion, ions, ionesfalseLinking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Veillonella parvula media profiling of IBD drug metabolitesST00247329466